Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/1555Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | REG.NO: BE0120006 | - |
| dc.date.accessioned | 2023-12-11T09:04:23Z | - |
| dc.date.available | 2023-12-11T09:04:23Z | - |
| dc.date.issued | 2023 | - |
| dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/1555 | - |
| dc.description.abstract | Background: Adenoid hypertrophy (AH) is a common disorder in children , which has a major impact on child’s growth and development [1] . Long term complications and sequelae of adenoidectomy such as alteration of immunological system, post operative bleeding, recurrence of adenoids and expenditure of the surgery are objects of criticism., hence this study will aim to reduce the need for the surgery by the addition of mometasone nasal spray in medical management of adenoid hypertrophy Objectives: The objective of the study is to determine if adding intranasal corticosteroids to the standard medical regimen has a better efficacy in treating chronic adenoiditis so as to avoid the need for surgery. | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | KLE Academy of Higher Education and Research, Belagavi | en_US |
| dc.subject | : Adenoid hypertrophy, Mometasone furoate, Nasal obstruction index, | en_US |
| dc.title | TO COMPARE THE EFFICACY OF ADDITION OF MOMETASONE NASAL SPRAY TO THE STANDARD MEDICAL TREATMENT IN REDUCTION OF ADENOID HYPERTROPHY IN CHRONIC ADENOIDITIS: A ONE YEAR RANDOMISED CONTROL STUDY | en_US |
| dc.type | Dissertations | en_US |
| Appears in Collections: | Otorhinolaryngology Head & Neck Surgery MS | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| BE0120006.pdf | 7.1 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.